In terms of body weight, glucose tolerance, and epididymal fat deposition, the enhanced activation of Nrf2 further improved the beneficial outcome of WD-induced NAFLD in L-selectin-deficient mice. Here, SELL is linked to metabolic dysfunction-associated steatotic liver disease.